PAVmed (PAVM) Operating Income (2016 - 2025)

PAVmed's Operating Income history runs 10 years deep, the most recent figure standing at -$6.8 million for Q4 2025.

• In Q4 2025, Operating Income fell 31.15% year-over-year to -$6.8 million; the TTM figure through Dec 2025 stood at -$21.8 million (up 55.76% YoY), while the FY2025 annual figure was -$21.8 million, up 50.98% from the prior year.
• Operating Income was -$6.8 million for Q4 2025 at PAVmed, down from -$4.8 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$4.7 million in Q2 2025 to a low of -$24.6 million in Q4 2022.
• Historically, Operating Income has averaged -$14.2 million across 5 years, with a median of -$14.0 million in 2024.
• The sharpest annual moves came in 2021 and 2024: Operating Income tumbled 160.44% in 2021, then surged 68.34% in 2024.
• A 5-year view of Operating Income shows it stood at -$19.7 million in 2021, then declined by 25.01% to -$24.6 million in 2022, then soared by 33.41% to -$16.4 million in 2023, then soared by 68.34% to -$5.2 million in 2024, then sank by 31.15% to -$6.8 million in 2025.
• The last three Operating Income figures came in at -$6.8 million (Q4 2025), -$4.8 million (Q3 2025), and -$4.7 million (Q2 2025), per Business Quant data.